DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Asenapine Maleate is a drug marketed by Alembic Pharms Ltd, Breckenridge, and Sigmapharm Labs Llc. and is included in three NDAs.
The generic ingredient in ASENAPINE MALEATE is asenapine maleate. There are twelve drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the asenapine maleate profile page.
A generic version of ASENAPINE MALEATE was approved as asenapine maleate by ALEMBIC PHARMS LTD on December 10th, 2020.
Summary for ASENAPINE MALEATE
Recent Clinical Trials for ASENAPINE MALEATE
Identify potential brand extensions & 505(b)(2) entrants
|Accutest Research Laboratories (I) Pvt. Ltd.||Phase 2/Phase 3|
|Amneal Pharmaceuticals, LLC||Phase 2/Phase 3|
|Sun Pharmaceutical Industries Limited||Phase 1|
Pharmacology for ASENAPINE MALEATE
|Drug Class||Atypical Antipsychotic |